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Summertime
Summertime, in the immortal words of George Gershwin, is 
when “the livin’ is easy” – that is, of course, unless one happens to 
be a medical student.
I imagine it must have been around last December when I and 
my wide-eyed colleagues began in earnest to agonize over what 
to do with almost three months of summer break. As if on cue, 
successive information sessions, electronic missives and travel 
brochures flooded our schedules, inboxes and backseat pouches, 
mesmerizing us with promises of staple guns, pipette guns and 
water guns. Inquiries and deliberations and applications ensued, 
then all was lost amid the busyness of the second semester.
In the end, I spent the majority of my summer with the 
MedQUEST program (now rechristened MedLINCS) in Seaforth, 
Ontario. There, I divided my time between frantically scribbling 
down clinical pearls gleaned from local healthcare professionals 
and running an interactive camp for high school students from 
the region. I emerged physically exhausted, perhaps, but with 
a definitely reinvigorated passion for medicine and medical 
education – so, I snagged up this sweet job, and now here we all 
are.
My first great responsibility, this congenial anthology-of-sorts 
which you are now perusing on your electronic device of choice, 
is a record of just a few of the many stories of summertime 
experiences that yearn to be shared. Some of these concern 
patient encounters: these run the gamut from heartbreakingly 
sincere, through intellectually challenging, all the way to 
something altogether unexpected and humbling. Others of these 
are stories of academic study and research, now told in the form 
of findings that are equal parts enlightening and sobering. Still 
others are concerned with good weather and better parties – 
these are adequately chronicled on Facebook and the like.
The fish might not always be jumpin’ and the cotton varies in 
height, but this collection of writings will always be a ready 
reminder of summertime memories. Read on to discover what 
sorts of things students of the Schulich School of Medicine & 
Dentistry were involved with over the summer of 2013.
Anthony Chow
Junior Associate Editor
edito ial
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A Case of Too Much Doggy Love
Melissa J MacPherson, PhD (Meds 2014)
Faculty Reviewer:  Dr John Payne, MClSc, MD, CCFP, FCFP (Department of Family Medicine)
A nimal bites, especially bites to the head, neck and face, are common injuries in children.1 It is estimated that in the pediatric population dog bites account for 0.3% 
to 1.5% of all presentations for medical care.1 Children are most 
likely to be bitten by a familiar dog at home and are frequently 
bitten due to a provoked attack.1-3 Appropriate adult supervision 
could prevent many of these bites from occurring. 
It was while I was on a rural family medicine rotation in Dres-
den, a small farming community of 2800 people in Southwestern 
Ontario, that I gained exposure to pediatric dog bite injuries. My 
sweet patient, an animal lover, was playing with a neighbour’s 
8-week-old puppy when the injury occurred. She picked up the 
puppy and squeezed him too hard and the puppy bit her ear in an 
attempt to escape; a very natural reaction for a small animal. She 
presented to the local emergency department where the wound 
was cleaned and closed using dissolvable sutures. The local health 
department was contacted and informed of her dog bite injury. The 
following day she presented to our clinic for follow-up care in the 
company of her mother, her older sister and her stuffed animal – a 
black doggy. It was in the family medicine clinic where I had the 
pleasure of meeting her and her four-legged stuffed companion.
Since the puppy at fault was only 8 weeks old, he had not yet 
received his immunizations. Our 3-year-old patient needed to un-
dergo rabies postexposure prophylaxis (PEP) treatment to prevent 
a fatal rabies infection. The unimmunized puppy lived on a farm 
where he theoretically could have been exposed to rabid wild an-
imals. He was placed under quarantine and underwent testing for 
the rabies virus. The Center for Disease Control in the United States 
recommends a quarantine period of 10 days for all unimmunized 
dogs involved in bite injuries.4 Animals are considered to be vacci-
nated against the rabies virus 28 days after the initial immunization 
since this is when peak rabies virus antibody titer is reached.4 All 
dogs are required to have booster shots on a yearly basis to ensure 
that their immune status against the virus is maintained.4-5 Unfor-
tunately, the puppy in our case was now in for a miserable 10 days of 
confinement so that he could be monitored for signs and symptoms 
of rabies.   
Rabies is caused by infection with the rabies virus: an envel-
oped, single-stranded RNA virus in the Lyssavirus genus and Rhab-
doviridae family.6 The virus infects the peripheral nervous system 
of mammals and undergoes retrograde axonal transport to the cen-
tral nervous system (CNS).7 Once the virus reaches the CNS it is 
universally fatal. From the CNS it spreads to multiple organs along 
both sensory and autonomic nerves.7 The disease has been feared 
globally for over 4000 years.6 It is the only virus known that has an 
acute case fatality rate of nearly 100%, making it among the most 
deadly viruses on Earth.6-7 The World Health Organization esti-
mates that rabies results in more than 50 000 deaths annually.6,8 
Most of these deaths occur in the developing world, especially in 
Asia and Africa, where dogs are not routinely immunized against 
the virus7 and PEP is not easily available or affordable for dog bite 
victims.6 In North America most cases of rabies occur due to bat 
bites.7 In the United States, there are fewer than 2 deaths annually 
from rabies.8 Once a patient has developed signs and symptoms of 
rabies, there are no effective measures to stop the progression of 
the disease. Timely rabies PEP is essential to preserve the life of a 
patient after a bite from a rabid animal.7         
The incubation period of the virus in humans is typically 20 
to 90 days.7 The prodromal symptoms are non-specific but may 
include early localized symptoms of pain, itching and paresthesia 
at the bite site.7 There are two presentations of the infection:  en-
cephalitic rabies and paralytic rabies.6 The encephalitic form of 
the disease occurs in approximately 80% of human rabies cases.7 
It is characterized by episodes of excitement and hallucinations 
with intermittent lucidity. Patients also have episodes of autonomic 
dysfunction and hydrophobia (fear of water).  Death usually occurs 
within 7 days.7 In the paralytic form of the disease, patients develop 
quadriparesis, flaccid muscle weakness and sphincter dysfunction. 
These patients are deceased within 2 weeks.7
Dogs infected by the rabies virus excrete the virus in the sali-
va.4 A bite is an effective method of inoculating a victim with the 
virus. In an animal, signs of infection include lethargy, fever, vomit-
ing, anorexia, cerebral dysfunction, cranial nerve dysfunction, atax-
ia, weakness, paralysis, seizures, abnormal behaviour, aggression 
and self-mutilation.4  
On her first visit to the clinic, day 0, our 3-year-old patient 
received a shot of HyperRAB human anti-rabies immunoglobulin 
near the site of her bite and a shot of Imovax rabies vaccine at a 
site distant from her bite. The HyperRAB, a pooled immunoglobu-
lin prepared from human donors with circulating anti-rabies anti-
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bodies, provides passive immunity against the rabies virus for up to 
3 weeks following administration.8 Timely treatment with Hyper-
RAB provides passive immunity to rabies before active immunity 
is acquired from vaccination with Imovax.8 Our patient received 
a second shot of Imovax vaccine on day 3 and a third shot on day 
7 postexposure. Once the puppy had been quarantined for 10 days 
and was still alive and healthy and had tested negative for the ra-
bies virus, our patient did not require the fourth injection of Imovax 
vaccine normally administered on day 14. A fifth dose of vaccine is 
administered on day 28 in patients who are immunosuppressed.6,8 
The side effects associated with HyperRAB and Imovax include lo-
cal reactions at the site of injection such as erythema, itching and 
swelling, as well as systemic reactions such as headache, nausea, 
abdominal pain, myalgia, dizziness and fever.8-9 These are similar 
to side effects seen with other vaccines.  Patients bitten by an ani-
mal should also receive a tetanus shot if their immunization status 
is not up-to-date.1 Our 3-year-old patient had received all of her 
scheduled tetanus vaccinations. If she were under 3 years of age, 
she would have required a tetanus vaccine on day 0.
Our patient was one of the estimated 15 million people world-
wide who receive PEP annually.9 The wound on her ear healed well 
and will not result in any disfigurement. At our last encounter, she 
told me that despite being bitten by a puppy she was not afraid of 
doggies. She then showed me how to gently pat doggies using her 
well-loved stuffed black dog. She had been practising.
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A Case of Symptomatic Severe 
Hypercalcemia in a 72-Year-Old Man
Cassandra Lin (Meds 2014), Tamara Chu (Meds 2014), Nathalie Sela (Meds 2014)
Faculty Reviewer:  Dr Noureen Huda, MBBS, FRCPC (Department of Medicine, Division of General Internal Medicine) 
case presentation
A 72-year-old gentleman was referred to the internal med-
icine clinic with a one-month history of cognitive and functional 
decline. Further history revealed progressive confusion, recurrent 
falls, abdominal pain associated with constipation, an unintentional 
30-pound weight loss, and nocturnal sweats for the past two years. 
His past medical history and family history were non-contributory. 
Physical exam was remarkable for tenderness in the coccyx region 
but was otherwise normal. His initial screening blood work showed 
a serum calcium level of 3.37 mmol/L (normal range 2.15-2.55). This 
suggested that his symptoms were likely a result of the elevated cal-
cium and he was admitted to the inpatient internal medicine ser-
vice for urgent treatment and further investigations.
Upon admission he was immediately started on intravenous 
normal saline 250 mL/h to help excrete the calcium and was given 
a single dose of intravenous pamidronate 90 mg to inhibit further 
calcium release. Further inpatient investigations were performed to 
assess etiology, and revealed an albumin level of 20 g/L (normal 35-
52) and corrected calcium level of 3.69 mmol/L.  The serum PTH 
level was 0.5 pmol/L (normal 1.6-6.9), suggesting that the parathy-
roid gland was responding appropriately to the elevated serum cal-
cium. The CBC demonstrated pancytopenia with a hemoglobin of 
99 g/L (normal 135-170), leukoctyes of 3.8 × 109 /L (normal 4-10), 
and thrombocytes of 92 × 109 /L (normal 150-400).  His hemato-
crit was 0.24 L/L (normal 0.4-0.5) and the reticulocyte count was 
normal at 43 × 109 /L, suggesting that the bone marrow (BM) was 
not able to respond appropriately to the anemia.  Moreover, the 
near-normal MCV of 97.3 fL (normal 79-97) favored an intrinsic BM 
disease.  Amongst other blood tests, the creatinine was elevated at 
169 µmol/L (normal 62-120). We did not have a previous creatinine 
for comparison.  The symptomatic hypercalcemia, normocytic ane-
mia, renal failure, and deep coccyx bony pain was suspicious for 
multiple myeloma and we proceeded with further diagnostic work-
up. 
Peripheral blood smear demonstrated rouleaux formation of 
red blood cells, ESR was 116 mm/h (normal 0-10), and protein lev-
el was 110 g/L (normal 64-83).  Serum protein electrophoresis was 
performed to find the source of elevated protein and this demon-
strated an abnormally elevated IgG lambda monoclonal protein. 
Urine protein electrophoresis was also performed and demonstrat-
ed the elevated monoclonal protein, along with free lambda light 
chains. As expected, serum IgG immunoglobulin was elevated at 
72.3 g/L (normal 6-13) and the other immunoglobulins were low, 
suggesting immune dysfunction secondary to suppressed plasma 
cell function. The presence of free light chains in the urine suggest-
ed that renal failure was secondary to tubular damage from cast ne-
phropathy.   The skeletal survey did not show any lytic lesions con-
sistent with myeloma except degenerative changes in the vertebrae, 
which may be the cause for our patient’s bony pain.  
BM biopsy revealed more than 60% infiltration of plasma cells 
and the flow cytometry markers were indicative of both monoclo-
nal plasma cells and lambda light chains. These investigations sug-
gested immune suppression and BM infiltration from an elevated 
monoclonal protein. Coupled with the clinical presentation of ane-
mia, hypercalcemia, and renal failure, this confirmed a diagnosis of 
IgG multiple myeloma (MM). 
initial presentation, epidemiology, and  
pathogenesis of mm
Hypercalcemia is a frequent problem among hospitalized pa-
tients with an estimated prevalence of 15%.1 The majority of cases 
are caused by primary hyperparathyroidism or malignancy.2 MM, a 
consequence of the latter, is a malignancy of plasma cells resulting 
in clonal proliferation of immunoglobulins. It causes extreme ab-
normal bone remodeling with over 80% of myeloma patients having 
bone disease,3 73% presenting with anemia at diagnosis,4 and 30% 
having renal insufficiency.5 It accounts for 1% of all cancers and 
roughly 10% of all haematological malignancies.6 It is thought that 
almost all MM patients start off with asymptomatic monoclonal 
gammopathy of undetermined significance (MGUS), which then 
progresses to MM at a rate of 1% each year.6 Sometimes there is 
an intermediate stage known as smouldering MM (SMM), which 
progresses to MM at a rate of 10% each year for the first five years.7
diagnosis and treatment of mm
Diagnosis of MM is based on serum and/or urine identification 
of monoclonal immunoglobulins or the presence of heavy or light 
chains, evidence of proliferation of plasma cells on BM, and inspec-
tion of lytic bone lesions.6 These diagnostic criteria can differenti-
ate between MGUS, SMM, and MM.  Symptomatic MM requires 
>10% infiltration of clonal plasma cells on BM biopsy and evidence 
of end-organ damage, commonly known as the CRAB criteria: hy-
percalcemia, renal insufficiency, anemia, and bone lesions.6
Symptomatic MM requires immediate treatment. Standard 
UWOMJ 82:S1 | Page 6 | Summer 2013
case report
treatment for healthy patients younger than 65 years includes in-
duction therapy followed by autologous stem cell transplantation. 
Patients older than 65 years with significant comorbidities should 
receive chemotherapy.  Two therapies are recommended in this 
clinical setting based on level 1A evidence: (1) melphalan/predni-
sone/thalidomine (MPT) and (2) bortezomib/melphalan/predni-
sone (VMP).8-9
case conclusion
Clinically, our patient responded well to IV fluids and pamid-
ronate.  The corrected calcium improved to 2.47 mmol/L and this 
coincided with an improvement in his mentation and abdominal 
symptoms.  The hematology service was consulted for definitive 
management of MM.  Given that our patient likely had lambda light 
chain cast nephropathy as the cause of renal failure, the hematolo-
gist suggested a pulse cycle of dexamethasone 40mg IV for 4 days 
on, 4 days off, and repeated once.  These cycles were a part of a 
chemotherapy regime consisting of oral melphalan and intravenous 
bortezomib.  Given our patient’s advanced age, he was not a candi-
date for BM transplant.  He was discharged with a normal serum 
calcium, full recovery from symptoms, and a prescription including 
instructions for the oral 4 mg pulse dexamethasone cycle. The he-
matology service took over further care and chemotherapy on an 
outpatient basis.   
Our patient’s follow-up includes bloodwork, serum and urine 
protein electrophoresis, creatinine, and calcium levels every 2-3 
months.  Furthermore, new onset of bone pain warrants thorough 
investigations to detect new bone lesions.7 Considering MM pa-
tients are living longer nowadays and suffering from resulting bone 
disease, it is important for future therapies to target novel media-
tors of bone destruction.10
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Intergenerational Trauma in Aboriginal Peoples 
The Importance of Understanding Historical Context as a Health Professional
Peter Cordell (Meds 2016)
Faculty Reviewer:  Dr Tara Somerville, MD 
background information
Aboriginal peoples (First Nations, Inuit, and Metis peoples) 
represent approximately 4% of the Canadian population1 and 1.7% 
of the population in the region served by the Southwest Local 
Health Integration Network (LHIN).2 In fact, Aboriginal peoples 
are the fastest growing population in Canada,2 with an average age 
that is significantly younger than that of the non-Aboriginal popu-
lation.1 However, Aboriginals face higher rates of chronic disease 
and a variety of challenges accessing care and therefore deserve 
particular attention.2 Although many efforts are underway to im-
prove health outcomes in Aboriginals, their health outcomes are 
still disproportionately poor in comparison to those of non-Aborig-
inal Canadians.3
Awareness of this disparity is not only important to health pro-
fessionals practicing in Northern Ontario, but also to those in the 
Southwest LHIN region, due to the number of Aboriginal people 
residing in this region.2 In London alone there are 4590 persons 
identified as First Nations people, another 1345 identified as Métis, 
and 80 identified as Inuit.4
case presentation
A 19-year-old male from an Ontario First Nations community 
presented for an appointment with his family physician at the local 
health centre complaining of arm pain. The patient had visited the 
local emergency room the day prior, but had been quickly released 
as his injuries were not the result of a fracture. 
The family physician assessed the patient’s injuries, which ap-
peared to be the reason for his appointment. However, further dis-
cussion revealed that the individual’s partner was physically violent 
and that the trend was escalating. On examination, the physician 
noted several abrasions, a cigarette burn, and a contusion on the 
patient’s back. After treating the injuries, the individual’s current 
living situation and safety were discussed. The individual described 
his willingness to end this abusive relationship and an action plan 
was created. Later in the appointment, as the patient felt more com-
fortable, he explained that he had considered suicide. His immedi-
ate risk of suicide was assessed and the reasons behind his suicidal 
ideation were explored. 
The individual had an extensive history of witnessing and ex-
periencing domestic violence in his childhood, as did his partner. 
The challenge, the physician described, is that in order to enter a 
healthy relationship, one must know what that looks like, whereas 
in this case, both individuals understood relationships in the con-
text of abuse and violence as this was their environment as children.
cultural safety
Cultural safety involves health professionals’ recognition that 
they bring their own culture and attitudes to the relationship with 
the patient and need to be respectful of the patient’s nationality, 
culture, age, sex, political and religious beliefs, and sexual orienta-
tion.5 In order to achieve cultural safety, health professionals must 
learn to move beyond the concept of cultural awareness – being 
aware that a difference exists—to analyzing power imbalances, in-
stitutional discrimination, colonization, and colonial relationships 
as they apply to health care.5
Recognition of the health disparity between Aboriginals and 
non-Aboriginals is critical for practitioners to adjust screening and 
treatment practices accordingly. However, this awareness can be 
harmful if it leads to the impression that Aboriginal people are in-
herently sick.6 Such an impression puts health professionals at risk 
of blaming Aboriginal people for their health status.3
abuse and intergenerational trauma
Sources of intergenerational trauma due to colonization include 
residential schools, forced relocation, involuntary sterilization, 
forced adoption, religious conversion, and enfranchisement.1 For 
example, residential school survivors experienced trauma through 
the abuse and violence that took place in the schools.7 Testimony 
from former students reveals the extremely harsh and hazardous 
living conditions at the schools, including hunger and malnutrition, 
poor heating and sanitation, inadequate clothing, and exposure to 
contagious diseases.8 Furthermore, many students suffered sexual, 
physical, and emotional abuse by the teachers and staff responsible 
for their care.8 The lack of proper treatment and conditions in the 
schools contributed to the deaths of thousands of children.8 This 
experience enacts its intergenerational effects through the relation-
ship between trauma and future family violence and abuse.
Domestic violence and abuse are almost always linked to trau-
ma.7 It is estimated that 3.2 million American children witness in-
cidents of domestic violence annually.9-10 When children grow up 
witnessing violence and abuse, they are far more likely to be vi-
olent themselves or to enter into abusive relationships.7 In fact, 
child witnesses have been found to display inappropriate attitudes 
about violence as a means of resolving conflict and indicate a great-
er willingness to use violence themselves.9,11,12,13 In the long-term, 
the future parenting and relationship skills of children are at stake.14 
Thus, trauma is both one of the primary causes as well as a principal 
outcome of domestic violence and abuse.7 This creates a challenging 
cycle to break due to its intergenerational effects.7 
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In 1999 Statistics Canada found that 25% of Aboriginal women 
and 13% of Aboriginal men reported experiencing violence from a 
current or previous partner over the past five years7 – the national 
average was 8% and 7% in Canadian women and men, respective-
ly, over the same period7. Subsequently, in 2009 Statistics Canada 
found that Aboriginal women were 3 times as likely as non-Aborig-
inal women to experience spousal abuse.15 This is especially alarm-
ing given that reports are much less frequent than the violence it-
self.14 The critical point to understand is that the current statistics 
on domestic violence and abuse in Aboriginals is intimately related 
to the intergenerational trauma sustained through colonization. 
This is demonstrated through the abuse cycle initiated by residen-
tial school survivors that have experienced violence and abuse. 
discussion
It is extremely important to understand the inequities and sta-
tistics regarding various illnesses and diseases in Aboriginal peo-
ples. However, when risk factors are removed from their historical, 
social, and economic contexts, there is a potential to encourage or 
reinforce the development of negative stereotypes.1 Health pro-
fessionals must recognize that colonization is a root cause of the 
negative health outcomes in Aboriginals.3 This recognition helps 
prevent the blaming of Aboriginal patients for their health-related 
behaviours.3
The experience of many Aboriginal People with the main-
stream health care system has been negative, often due to cultural 
differences.5 Frequently, cultural differences and the inability of 
health professionals to appropriately address these in a culturally 
safe manner have contributed to high rates of noncompliance and 
reluctance to visit mainstream health facilities.5 Consequently, this 
has left Aboriginal patients with feelings of fear, disrespect and 
alienation.5 Cultural safety conversely entails respectful communi-
cation, empowers the patient, and improves quality of care.5
Due to the inherent power imbalance present in the health-pro-
fessional-to-patient relationship,1 it is the responsibility of the health 
professional to pursue training in cultural safety as it pertains to Ab-
original peoples. This knowledge is especially important given the 
health inequity faced by Aboriginals, as well as the aforementioned 
population demographics for the Southwest LHIN region.
In conclusion, it is critical for health professionals to be aware of 
the difference in health outcomes in Aboriginal peoples, while being 
sure not to stereotype Aboriginal patients based on these statistics.3 
Health professionals must work together with Aboriginal communi-
ties to provide community-directed and culturally safe solutions that 
disrupt the cycle of abuse stemming from colonization.
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An interesting case of preseptal cellulitis
Eddie Liu (Meds 2014)
Faculty Reviewer:  Dr Saira Zafar, MD, FRCPC (Department of Medicine, Division of General Internal Medicine) 
case presentation
A 39-year-old woman presents to the Emergency Department 
with swelling and erythema of her face involving the right eye. Her 
symptoms were preceded by a 6-day history of sore throat, fever 
and chills. Her medical history is significant for depression and she 
is on sertraline 25 mg P.O. daily. On exam the patient had diffuse er-
ythema and swelling in the lower half of her forehead and the entire 
region surrounding her right eye. Her right eye was swollen shut. 
Gross examination of the eye revealed no proptosis, no ophthalmo-
plegia and normal ocular movements. Pupils were round and equal 
with normal direct and consensual response.  A CT scan of the head 
showed no involvement of the orbit and sinuses. Blood culture, 
urine culture and antistreptolysin O titre (ASOT) were all negative. 
Interestingly, the patient’s husband was admitted to hospital a few 
days earlier with aggressive leg cellulitis and her child recently had 
strep throat and impetigo. Although no infectious organism was 
identified in this patient, Streptococcus pyogenes was isolated in 
an area of cellulitis on her husband’s leg. For this reason, she was 
treated for S. pyogenes with ceftriaxone 1 mg IV OD for three days 
followed by cefuroxime 500 mg P.O. BID for 10 days. 
discussion
It is important to distinguish between preseptal cellulitis and 
orbital cellulitis. The two conditions share similar clinical symp-
toms of ocular pain and eyelid swelling and erythema, but they have 
drastically differently clinical implications.1 Preseptal cellulitis, 
also known as periorbital cellulitis, is an infection of the anterior 
portion of the eyelid. It is generally a mild condition that rarely 
leads to serious complications.5 Conversely, orbital cellulitis is an 
infection that involves the contents of the orbit, such as the ocular 
muscles and fat, but not the globe.2 Orbital cellulitis can cause loss 
of vision and can be fatal. Clinical features that indicate orbital cel-
lulitis include ophthalmoplegia, pain with eye movement and pro-
ptosis.7 In addition, imaging studies such as CT scans of the head 
can help to distinguish between the two.1 Even though preseptal 
cellulitis is more common than orbital cellulitis, in cases where dis-
tinction is unclear, patients should be treated as though they have 
orbital cellulitis due to the serious complications associated with 
untreated orbital cellulitis. In the case above, the patient exhibit-
ed clinical symptoms indicative of preseptal cellulitis and CT head 
ruled out any orbital involvement. 
The treatment for preseptal cellulitis is usually empirical and 
depends on knowledge of the common infecting organisms and 
their antibiotic susceptibility.3 The most common organisms in-
clude Staphylococcus aureus, Streptococcus pneumoniae, other 
streptococci and anaerobes. If orbital cellulitis is suspected, a re-
ferral to an ophthalmologist should be made for further inves-
tigations.6 In this case the infectious organism was likely to be S. 
pyogenes because two of the patient’s family members had recent 
streptococcal infections: cellulitis, strep throat and impetigo.  It is 
interesting that her ASOT was tested negative; however the test is 
associated with a false negative rate of 20% - 30% and does not de-
finitively rule out a streptococcal infection on its own.4
summary
Preseptal and orbital cellulitis are two conditions that share 
similar clinical symptoms of swelling, erythema and ocular pain. 
Although preseptal cellulitis is more common and generally a mild 
condition, it is important to distinguish it from orbital cellulitis, 
which can lead to loss of vision and death. A careful history and 
physical can be extremely helpful in distinguishing the two condi-
tions and may lead to identification of the offending organism. CT 
scans of the head are often advisable to rule out orbital and sinus 
involvement. Preseptal cellulitis is a condition that can be managed 
by antibiotics as an outpatient. If orbital cellulitis is suspected, how-
ever, an ophthalmology referral is warranted and hospital admis-
sion is strongly recommended. 
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New-onset psychogenic non-epileptic 
seizures in a patient with epilepsy 
The importance of inpatient monitoring on an epilepsy unit 
to ensure appropriate diagnosis and treatment
Kendra L Derry (Meds 2015)
Faculty Reviewers:  Dr Paul A Derry, PhD (C Psych) (Department of Psychology) & 
Dr Jorge G Burneo, MSPH, MD (Department of Clinical Neurological Sciences)
introduction
Epileptic seizures are paroxysmal behavior patterns due to cen-
tral nervous system (CNS) dysfunction.1 Psychogenic non-epileptic 
seizures (PNES) are disorders that can be mistaken for epilepsy. 
However, unlike genuine epilepsy, PNES are not the consequence 
of abnormal electrical discharges in the brain. The Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 
categorizes PNES under Somatoform Disorders: Conversion Dis-
order along with seizures or convulsions.2 PNES involves uncon-
scious physical manifestation of psychosocial distress.
As PNES and epileptic seizures share many features, it can be 
difficult to differentiate between the two.3 Diagnosis of PNES is fur-
ther complicated in cases where there is a concomitant diagnosis of 
epilepsy. Data suggests that the prevalence of co-existing epilepsy 
with PNES lies between 10 and 50%.4-7
It is important to accurately diagnose PNES because treatment 
regimens that are appropriate for epileptic seizures (medication 
and possible epilepsy surgery) are inappropriate, ineffectual, costly 
and potentially harmful in the treatment of PNES. 
We present a case of new onset PNES in a patient with pre-
viously diagnosed epilepsy. This case exemplifies how an accurate 
diagnosis, achieved through admission to the Epilepsy Monitoring 
Unit (EMU), can drastically alter prognosis and management. This 
case also highlights the importance of a multidisciplinary approach 
when dealing with conversion disorders. 
case presentation
Ms X is a 44-year-old married woman who was admitted to the 
University Hospital EMU in August 2013, for re-investigation as a 
surgical candidate for her previously diagnosed epilepsy. 
In March of 2004 Ms X experienced her first seizure. On No-
vember 7, 2006 Ms X was admitted to the EMU for investigation. 
Subdural electrodes were implanted and localized the origins of the 
seizures to the left anterior temporal and left orbitofrontal region. 
A diagnosis of left fronto-temporal epilepsy was made. At this time 
Ms X was offered a left temporal lobectomy plus posterior inferi-
or frontal lobectomy.  The subdural electrodes were explanted on 
November 30, 2006 with no complications, and the patient was 
discharged home December 1, 2006 with full medications. At the 
time, Ms X wished to proceed with surgery and was to be sched-
uled for the procedure. On December 14, 2006 Ms X presented to 
the Emergency Room in London with a headache. It was discovered 
that she had developed bilateral temporal lobe abscesses. Incision 
and needle drainage of the left postero-temporal brain abscess was 
performed and ceftriaxone was administered for 6 weeks. Ms X re-
covered well from the infection and it was the surgeon’s opinion 
that her infection would not interfere with her ability to undergo 
surgery. However, the patient decided to defer surgery and opted 
for medical management. 
With continued problematic seizures, Ms X recently decided 
she wished to pursue surgery. As is standard practice, she was re-ad-
mitted for further seizure monitoring to confirm seizure origin. In 
contrast to the seizure activity recorded in 2006, all events record-
ed during her 2013 evaluation revealed entirely normal EEGs. No 
epileptic seizures were recorded. Ms X did however, experience 
numerous PNES which were recorded via continuous EEG/video 
monitoring. In contrast to her seizures in 2006, her current spells 
are long in duration (5 to 45 min) and non-stereotyped, with asyn-
chronous thrashing of arms and legs and retained consciousness. 
The patient reported she experiences about one event per day. 
Ms X’s past medical history is significant for migraines (once 
per week), anxiety disorder with panic attacks and an anoxthalmic 
left eye. 
Medications at the time included 
1. Atenolol 50 mg
2. Vimpat 200 mg twice daily
3. Topamax 100 mg twice daily
4. Dilantin 350mg once at nighttime 
Ms X has a significant psychological history. As a teenager she 
was in a physically abusive relationship and she was sexually as-
saulted. In early adulthood, her first husband and her father both 
unexpectedly passed away. Three years ago she suffered multiple 
leg fractures in a serious snowmobile accident, and underwent sev-
eral surgeries and significant rehabilitation. 
 On admission, Ms X’s physical examination, including a de-
tailed neurologic exam, was normal. 
Psychological assessment included formal psychological test-
ing, which indicated the diagnosis of conversion disorder.
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discussion
The absence of electrographic evidence of epileptic seizures 
during Ms X’s most recent admission to the EMU was an unantici-
pated finding.  In 2006, her EEG recordings showed clear evidence 
of left fronto-temporal epilepsy. No PNESs were recorded at that 
time. Over the nine years since her diagnosis, it was presumed her 
epilepsy was refractory to medical therapy, as her seizures were un-
controlled by medications alone. Epilepsy surgery seemed to be the 
most appropriate treatment option for this patient. The importance 
of re-investigating her is demonstrated by the realization that her 
epileptic seizures are now apparently well-controlled, and that her 
problem is caused by new symptoms that are non-epileptic in ori-
gin. Discovering this prevented brain surgery and allowed for im-
plementation of appropriate treatment. 
The diagnosis of PNES can be difficult. Intensive video-EEG 
monitoring in the EMU remains the gold standard for the diagnos-
tic evaluation of patients with conversion disorder.8 Video-EEG 
simultaneously records a patient’s behavior and brain electrical ac-
tivity.9 When video-EEG monitoring captures a characteristic spell 
while the EEG background is normal before, during and after the 
event, a diagnosis of PNES should be considered. 
Although there are no pathognomonic clinical signs that dis-
tinguish PNES from epileptic seizures, there are some risk factors 
and warning signs. Psychogenic seizures are characteristically lon-
ger in duration,10 with motor manifestations that tend to involve 
non-stereotyped, asynchronous, non-rhythmical thrashing of the 
extremities.11 This is in comparison to epileptic seizures which (1) 
tend to onset earlier in life, (2) are usually brief and stereotyped and 
(3) generally respond at least somewhat to medication. Additional-
ly, retained consciousness and retrospective recall of ictal events is 
more indicative of PNES.
Psychiatric comorbidities are also common in patients with 
PNES. The most common include depression, anxiety,12 post-trau-
matic stress disorder and personality disorders.13 A history of phys-
ical abuse is more likely in PNES (~75%) than in epilepsy (~42%). 
Further, the rate of sexual abuse is higher in the PNES population 
(~42%) compared to the epilepsy population (19%).10
Ms X has a good prognosis. She accepts that her current spells 
are psychogenic in origin and she is attending counseling. Since no 
epileptic seizures were recorded during her admission, we assume 
that her epilepsy is well controlled with medications. It is not un-
common for epileptic medications to be increased and/or added 
to the regime to attempt to control seizures in cases similar to this 
one. Inappropriate treatment, however, exposes the patient to the 
adverse effects of antiepileptic drugs and socioeconomic hardships 
– patients may be unable to work or drive or have limited social ac-
tivities – and adds to the burden on healthcare resources. 
In summary, this case highlights the difficulty in distinguish-
ing between epilepsy and PNES, and emphasizes the importance 
of both neurological and psychological evaluation for developing a 
correct diagnosis. It is important to appreciate that some patients 
with PNES also have genuine epileptic attacks that do require anti-
convulsant medications. 
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Double miss by ultrasound of a cornual ectopic pregnancy
Daniel Myran (Meds 2014)
Faculty Reviewer: Dr Meagan O’Brien, MD, FRCSC
abstract
Cornual ectopic pregnancy is a rare subtype of ectopic preg-
nancy that is associated with later presentation and higher 
likelihood of mortality. Despite advances in sonography cor-
nual ectopic pregnancies remain a challenging diagnosis. We 
present a case of a left cornual pregnancy that was initially in-
terpreted as a live intrauterine pregnancy by sonographic ex-
amination and found during repeat assessment to be a cornual 
pregnancy. 
introduction
Ectopic pregnancy, a pregnancy occurring outside the uterus, 
is one of the most common causes of first trimester bleeding and 
the most common life-threatening emergency in early pregnancy.1 
Currently, 2% of pregnancies result in an ectopic pregnancy, of 
which 95% occur in the body of fallopian tubes.2 Interstitial ec-
topic pregnancies (cornual pregnancies) are a rare subtype of ec-
topic pregnancy, resulting when implantation occurs in the most 
proximal part of the fallopian tube. Cornual pregnancies occur in 
approximately 2 to 4 percent of ectopic pregnancies or 1 in every 
2500 to 5000 pregnancies.3 Cornual pregnancies are a life-threat-
ening condition with an associated maternal mortality rate of 2 to 
2.5% compared to the overall 0.14% mortality rate for ectopic preg-
nancy.3,4
We report here a case of a cornual pregnancy that was twice 
interpreted by sonographic examination as a normal intrauterine 
gestation before diagnosis and treatment with an open resection. 
case presentation
A 33-year-old woman, gravida 6, para 3 with two previous mis-
carriages, presented to the emergency department with a one-week 
history of left lower quadrant pain that had worsened over the past 
24 hours. In addition, the patient noted vaginal spotting occurring 
in the past 24-hour period. Her menstrual periods had been regular, 
lasting 5 days with a 28-day cycle. At the time of presentation she 
was at 10 weeks gestation age by last menstrual period. The patient 
was otherwise healthy with no previous pelvic surgeries, no known 
history of sexually transmitted infections, and no history of assisted 
fertilization. 
Vitals of the patient at triage were as follows: blood pressure 
100/73, temperature 36.2°C, heart rate 81, and respiratory rate 16. 
Physical exam showed a stable, well-appearing 33 year old with 
scant vaginal bleeding. A solid tender mass in the left lower quad-
rant was palpated. 
investigations
A transabdominal ultrasound, performed one week prior at an 
outside institution for routine dating, was interpreted as showing a 
viable intrauterine pregnancy at 10 weeks gestation. A bedside trans-
abdominal ultrasound performed by the emergency physician on 
call at the time of presentation was interpreted as showing a viable 
intrauterine pregnancy. Given the clinical picture, formal repeat ul-
trasound in the radiology department was conducted on the follow-
ing day. Ultrasound findings were “an empty uterus and a gestational 
sac and embryo with motion and cardiac activity located in the left 
adnexal region with a moderately prominent endometrial canal.”
The patient was taken for emergency laparotomy. A nonrup-
tured amniotic sac measuring 5 x 5-cm with a fetus inside (pictured 
below) was visualized and removed. A left salpingectomy and re-
pair of uterine cornua were performed and the incision was closed. 
The patient had an uneventful postoperative course and was dis-
charged from hospital.
discussion
anatomy
The anatomy of a cornual pregnancy is responsible for both 
its late presentation and increased mortality. Cornual pregnancies 
are located in the proximal portion of the fallopian tube and sur-
rounded by the muscle of the myometrium. The surrounding myo-
metrium allows for greater distensibility before rupture and results 
in presentation at later stages than in a typical ectopic pregnancy, 
often as late as 12 to 16 weeks.4 The cornual implantation site is also 
located between the uterine and ovarian arteries. Consequently, ex-
pansion and rupture of the implantation leads to increased risk of 
life-threatening hemorrhage.5
Image 1: Intact cornual ectopic pregnancy removed from patient. 
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risk factors
Risk factors for cornual pregnancy are the same as those for 
ectopic pregnancy. These include pelvic inflammatory disease, pre-
vious pelvic surgeries including ruptured appendix, uterine abnor-
malities, and artificial fertilization.5
diagnosis
Of any pregnant patient presenting to the emergency room 
with first trimester bleeding or pain, 6 to 16% will have an ecto-
pic pregnancy.5 Even with a high index of suspicion and advances 
in sonography, including transvaginal sonography and serum beta 
hCG, cornual pregnancy remains the most difficult type of ectopic 
pregnancy to diagnose due to the low sensitivity and specificity 
of symptoms and imaging.3 The classic diagnostic triad of ectopic 
pregnancy - abdominal pain, amenorrhea, and vaginal bleeding - 
occurs in less than 40% of patients with cornual pregnancy.5 This 
triad is also present in ectopic pregnancy, threatened, and incom-
plete abortions. Cornual pregnancies show fewer early symptoms 
due to the increased distensibility of the uterine wall.6 The site of 
implantation also makes the pregnancy difficult to differentiate 
from an intrauterine pregnancy on ultrasound.4,7 As was seen in our 
case, transabdominal ultrasound can miss the diagnosis as the preg-
nancy may appear to be in an intrauterine location. 
treatment
With the development and increasing availability of transvag-
inal ultrasound, the diagnosis of cornual pregnancy is more fre-
quently being made before rupture. 
Traditionally cornual ectopic pregnancies were treated with 
hysterectomy. The current gold standard for a cornual pregnancy is 
a diagnostic laparotomy followed by a cornual wedge resection. Re-
cent surgical advances have demonstrated that operative laparos-
copy is a possible alternative in a stable patient with no suspicion 
of rupture.8
Conservative methods of treating cornual ectopic pregnancies 
include systemic administration of methotrexate and laprasco-
py-assisted or ultrasound-guided injection of methotrexate into the 
gestational sac.1 Conservative methods have been demonstrated to 
have an up to 65% success rate with systemic treatment.9 Local in-
jections appear to be more effective but are operator dependent.9 
All conservative methotrexate-based therapy is dependent on a sta-
ble patient and early diagnosis. 
conclusion
Cornual pregnancy remains a rare but significant diagnostic 
challenge. With increasing use of assisted reproductive technologies 
its incidence is expected to rise. A high index of suspicion should 
be maintained in any patient presenting with heavy bleeding during 
the first trimester. Repeat sonographic assessment is essential even 
in light of a “normal” intrauterine pregnancy if a patient’s symptoms 
are consistent with ectopic pregnancy. Diagnosis before rupture is 
essential to prevent mortality and potential loss of fertility. 
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Image 2. Ultrasound image from patient left sagittal view of uterus showing 
gestational sac on cornua. 
Image 3. Ultrasound image from patient showing the crown to rump length (CRL) 
for gestation. CRL is used to date early pregnancies; it is highly reproducible and 
up to 12 weeks is the best way of predicting gestational age. Our patient’s CRL 
showed an 11-week 2-day gestation. 
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Shades of Gray
The sex factor is not always black and white
Noor Jawaid (Meds 2015)
Faculty Reviewer: Dr Norman Furtado, MD, CCFP (Department of Family Medicine)
case presentation
Patients with complex healthcare needs are the mainstay of 
medicine today. In order to simplify management, physicians clas-
sify their patients’ symptoms, risk factors and medical histories into 
categories. A category commonly used by healthcare practitioners 
and researchers alike is “sex”, since in many diseases, sex can play an 
important role in attributing level of risk. ML, 64 years old and SL, 66 
years old, are two patients who do not fit neatly into such categories. 
They are a transgendered, surgically reconstructed married couple, 
who are both female. I had the pleasure of meeting them on a rural 
family medicine rotation where they presented together, as they al-
ways do, on a follow up appointment regarding their many compli-
cated medical issues. 
One was tall with cascading platinum blonde ringlets (a wig on 
closer inspection), the other wore her hair in a low-slung ponytail 
and wide-brimmed sun hat – both found exquisitely individual ways 
to hide their male-patterned baldness in their current female life. 
Right away, their openness and matter-of-fact manner made it easy to 
honestly question them about their past, present and future. ML and 
SL both had their gender reassignment surgeries conducted in Mon-
treal in 1989. Opting for the same type of surgery, each had their penis 
and scrotum removed and a vaginal vault constructed but retained 
their prostate. Their surgeries went well and they now live a happy 
life together, spending half the year in Canada and the other half in 
the southern United States golfing. They are highly aware of their 
medical issues and actively involved in each other’s health. Each one 
suffers from major conditions with a few notable examples which are 
placed in sharp focus when discussing risk factors related to “sex” in 
this unique couple.
using ‘sex’ as a defining feature in research
Some of their health needs are easily taken care of because they 
strictly involve screenings for men or women – in this case, both are 
applicable. For instance, despite being female, since ML and SL still 
have their prostates and are over the age of 50, as recommended by 
Canadian guidelines, they receive their prostate cancer screenings 
via DRE testing.1 Furthermore, SL has a positive immediate family 
history of prostate cancer which would usually require more vigilant 
monitoring, but with taking estrogen and removing her testicles, her 
risk becomes much lower. To add to their repertoire of annual screen-
ing, they also take part in the Ontario Breast Screening program for 
women over 50. Just because they now live their lives as females does 
not mean that they can erase the risks they were born into as males.
Other health needs, such as ML’s impaired glucose tolerance and 
SL’s full blown diabetes, are more difficult to keep track of. Physicians 
use “sex” as a useful marker to improve their estimates of risks that 
apply to their patients, but what happens when the research is tell-
ing you two different things? The MONICA Augsburg Cohort Study 
examines sex difference in risk factors for type 2 diabetes and finds 
some interesting patterns.2 Systolic blood pressure, smoking and 
high daily alcohol intake predict diabetes development only in men 
whereas uric acid and physical inactivity are factors associated with 
women. It is a difficult decision for the family physician as to which 
of these factors apply to patients like ML who need to be monitored 
closely for the possible development of diabetes. There is a similar 
dilemma present regarding cardiac health risk factors: ML and SL 
suffer from hypertension, dyslipidemia, hypercholesterolemia and a 
certain love for red meat and bacon. Some of these conditions have 
been shown to be greater risks for women in the development of 
coronary heart disease, while others are more dangerous in men.3 In 
such cases, even meticulously conducted research has its limitations 
in application to unique patients like ML and SL
discussion
The role of the family physician is paramount in the care of 
patients like ML and SL who have extra risk factors and screening 
needs. As discussed, research performed with males and females in 
mind can only provide so much information in the case of certain pa-
tients. The scenario is further convoluted when patients present with 
uncommon medical backgrounds with which the average physician 
may be unfamiliar. Information about less common procedures such 
as gender reassignment surgeries should be made available especial-
ly early on in the training of medical professionals.4 These patients 
must be cared for with great sensitivity for their unique needs and be 
understood in the context of each person as an individual. Patients 
should be treated as wholes regardless of the complexity of their 
medical needs – male, female or both.
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